Vimarsana
Biggest News Aggregation in the World

Page 23 - Program Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Program Updates Today - Breaking & Trending Today

Silence Therapeutics plc: Silence Therapeutics Reports First Quarter 2023 Results - Vimarsana News

Silence Therapeutics plc: Silence Therapeutics Reports First Quarter 2023 Results

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision

Türkiye: Cash-based Interventions Technical Working Group Online Meeting - April 19, 2023 - Türkiye - Vimarsana News

Türkiye: Cash-based Interventions Technical Working Group Online Meeting - April 19, 2023 - Türkiye

Other in English on Türkiye about Coordination and Earthquake; published on 19 Apr 2023 by UNHCR

Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update

-  NDA submission for etripamil in patients with PSVT currently on track for 3Q23 -  Company to host virtual KOL event focused on etripamil for the potential treatment of AFib-RVR on... | May 11, 2023

Veru Reports Fiscal 2023 Second Quarter Financial Results - Vimarsana News

Veru Reports Fiscal 2023 Second Quarter Financial Results

11.05.2023 - Agreement reached with FDA on confirmatory Phase 3 clinical trial design for sabizabulin treatment of hospitalized COVID-19 adult patients at high risk for acute respiratory distress syndrome (ARDS), including two planned interim efficacy analyses ...

Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates - Vimarsana News

Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...